Thomas D. Schmittgen is an associate professor in the College of Pharmacy at Ohio State University. He received his B.S. and Ph.D. at Ohio State. Following a post doc at the University of Southern California, he spent 7 years on the faculty at Washington State University before returning to Ohio State in 2002. For the past 7 years he has been working on the role of noncoding RNAs in cancer. Dr. Schmittgen developed the first real-time quantitative PCR assay to detect microRNA in 2004. He is currently working to develop microRNA-based biomarker assays for the early detection of pancreatic cancer.
Drug DiscoveryGenomicsInformatics